Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately ...

Scientists at the University of Glasgow have successfully used the first bioengineered bone marrow model to carry out vital ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A ...

Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial Studying 767 children ...

Learn about B-Cell Acute Lymphoblastic Leukemia (B-ALL), its symptoms, diagnosis, causes, and treatment options. Understand ...

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists from Rutgers Health and collaborating institutions have uncovered why a wid ...

Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...

Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ALL patients. Chimeric antigen receptor (CAR) T-cell therapy has shown promise in inducing ...

Blinatumomab, a new drug for childhood leukemia, has been a game-changer for young patients, allowing them to live more normal lives while undergoing treatment.